Skip to main content
Celltrion, Inc. logo

Celltrion, Inc. — Investor Relations & Filings

Ticker · 068270 ISIN · KR7068270008 LEI · 988400JFZG785WJX3D68 KO Manufacturing
Open in API
Filings indexed 1,287 across all filing types
Latest filing 2026-06-04 Major Shareholding Noti…
Country KR South Korea
Listing KO 068270

About Celltrion, Inc.

https://www.celltrion.com/

Celltrion, Inc. is a biopharmaceutical company that provides integrated solutions across the entire value chain, from research and development to clinical trials, regulatory affairs, and large-scale manufacturing. The company specializes in developing and producing innovative therapeutics, including biosimilars and novel biopharmaceuticals. Its portfolio primarily targets autoimmune diseases and oncology. Celltrion is recognized for launching the world's first monoclonal antibody biosimilar. A key product is ZYMFENTRA® (infliximab-dyyb), a subcutaneous formulation for the maintenance treatment of moderately-to-severely active Crohn's disease and ulcerative colitis. The company also develops and manufactures chemical pharmaceuticals.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 92% confidence The document is a detailed “주식등의 대량보유상황보고서(일반)” (large shareholding status report) under Korean capital markets law, listing the reporting entity, its substantial shareholdings, changes in share counts, percentages, and reasons for the change. This matches the definition for Major Shareholding Notification (MRQ), as it discloses changes in significant share ownership levels.
2026-06-04 Korean
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Governance Information Classification · 85% confidence The document is a Korean statutory disclosure of the corporate group status and detailed governance information for Celltrion, including affiliated companies, board composition, committee activities, and ESG-related governance metrics. It is not an earnings release, financing update, or proxy solicitation, but a governance report outlining internal governance structure and operations. This aligns with the Governance Information category (CGR).
2026-06-01 Korean
기업지배구조보고서공시
Governance Information Classification · 90% confidence The document is a substantive corporate governance report (“기업지배구조 보고서”) covering the company’s governance policies, board composition, committee structures, key governance indicators, and related detailed disclosures for the fiscal period. It is not merely an announcement of a report or a proxy statement; it is the full governance report itself. This aligns directly with the Governance Information category (CGR).
2026-05-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a Korean regulatory filing titled "임원ㆍ주요주주 특정증권등 소유상황보고서" (Report on Ownership of Certain Securities by Officers and Major Shareholders). It details an officer’s personal share transactions (a sale of 3,000 shares) filed with the securities regulator and exchange. This matches the definition of Director's Dealing (insider transactions) under code DIRS.
2026-05-29 Korean
투자판단관련주요경영사항 (CTP6 SC(허쥬마 피하주사 제형) 한국 품목허가 신청)
Regulatory Filings Classification · 85% confidence The document is a Korean stock exchange regulatory disclosure (“투자판단 관련 주요경영사항”) announcing the company’s application to the MFDS for product approval and detailing clinical trial results. It does not contain financial statements or formal report data, nor does it announce board changes, dividends, mergers, or financing. It is a general compliance announcement and thus falls under the Regulatory Filings (RNS) category.
2026-05-28 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change Classification · 98% confidence The document is a ‘주요사항보고서(무상증자결정)’, i.e. a formal announcement of a bonus share (free share) capital increase, detailing the number of new shares, par value, allocation date, record date, listing date, decision date, and related procedures. This fits the definition of a Share Issue/Capital Change. Category Code: SHA.
2026-05-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.